Educating Through Medical Animations, Cases and More | Free CME Activities

Interactive Cases

Search

Filter Content

Page 2 of 8

Results 76 - 150 of 537

Treating HCC Cases with Locoregional and Systemic Therapies

Evolving Systemic Treatments for Hepatocellular Carcinoma: Multidisciplinary Strategies

Biomarker-Driven Treatment of Metastatic Colorectal Cancer

Identifying the Signs and Symptoms of PPF

Treating & Assessing Treatment Response: AL Amyloidosis

The Advancing Treatment Landscape in Amyloidosis: Are You Ready?

Identify the Etiology of Aplastic Anemia in Patients

Recognizing Risk and Benefits of Management Options for Aplastic Anemia

Considerations for Special Populations With Aplastic Anemia

Stroke Prevention Through Afib Recognition & Treatment

Immune Checkpoint Inhibitors and RCC: Where Are We Now?

9171-ash-explore

Gene Therapy for Hemophilia: An EXPLORE Learning Experience

Evolving Treatment Options for the Treatment of HCC with Immunotherapy and LDT

01.DMD-VirtueMart5

DMD Micro-Learning Library

cttp_thumb_264x150

cTTP: Protecting Patients, Today and Tomorrow

9170-0011_263x149

DMD Conference Coverage: ICNMD and WMS

9156-LSD-264x150

Understanding Lysosomal Storage Disorders: From Newborn Screening to Treatments

9162-0001-DMD_264x150

Gene Therapy and the Future of DMD Treatment: An EXPLORE Learning Experieince

9165 pneumo explore

Utilizing ACIP's Updated Pneumococcal Recommendations

9152-sma-explore

Updates in Spinal Muscular Atrophy: An EXPLORE Learning Experience

Growing Importance of Newborn Screening in DMD

The Immune Response in DMD Gene Therapies

New Data from Gene Therapy Clinical Trials in DMD

Changing the Phenotype of DMD

DMD and Gene Therapy: What's on the Horizon?

CAR T-Cell Therapy Consults: Navigating a New Landscape

9167-0001-263x149

Treating Persistent/Chronic ITP: Current Care, Future Potential

Am I Treating My Patients With Psoriatic Disease Effectively?

Am I Treating My Patients with Psoriatic Disease Effectively?

Strategies for Assessing and Managing DOAC-Related Bleeding

Managing Side Effects of Newer Therapies for Acute Lymphoblastic Leukemia (ALL)

Reducing the Risk of Severe Illness for Patients With COVID-19

Emerging Treatments in Chronic GvHD

Treatment of Ph+ Relapsed/Refractory ALL

Treatment of Ph- Relapsed/Refractory ALL

Treating Complex Cases of NTM-LD

NTM-LD Diagnosis and Management

Emerging Nonfactor Approaches for Patients with Hemophilia

Identification of Relapsed ALL

ILD Patient Case Library: IPF, PF-ILD, SSc-ILD, and Post COVID-19

PAH: Risk Reduction Strategies Using Single and Combination Therapies

Ensuring Effective Care Transitions in Beta Thalassemia

Improved Patient Outcomes in PAH

Principles of Management of Chronic GVHD

Diagnosing and Assessing Chronic Graft-versus-Host Disease

IPF Management and Antifibrotic Therapy

How to Develop an Effective Risk Reduction Strategy in Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension (PAH) - Therapy Options Explained

Updates in Duchenne Muscular Dystrophy: A Focus on Emerging Gene Therapy

EXPLORE Learning Experience: COVID-19 and Monoclonal Antibodies

EXPLORE Learning Experience: Understanding and Managing NTM-Lung Disease

Cardiac Amyloidosis: Is It A Zebra or A Horse? Webinar Summary Module

Cardiac Amyloidosis Webinar #4: Treatment of Cardiac Amyloidosis

Cardiac Amyloidosis Webinar #3: Establishing the Correct Diagnosis

Cardiac Amyloidosis Webinar #2: Cardiac Imaging Pearls

Cardiac Amyloidosis Webinar #1: Who Should I be Testing?

Updates in Diabetes Care for Primary Care Providers

Osteoporosis Updates: Primary Care’s Critical Role

Primary Care and Dyslipidemia: What Should You Do?

Staying Current in Obesity Management: Key Updates for Primary Care

Thyroid Assessment: Updates for Primary Care

A New Paradigm in Treating ILD

A Collaborative Approach to IPF Management

Practical Solutions to SSc-ILD Treatment

Post COVID-19 and Patients With and Without Pre-existing ILD

Exploring CGM: Achieving Treatment Goals Together

Reversing DOACS: Providing Answers to What, Where and How

How to Choose the Right Therapy for Your Patients with IPF

PAH: Aligning Treatment Strategy to Risk Level

PAH: Identifying Side Effects and Optimizing Therapy to Improve Patient Outcomes

LGMD: Mutation-specific Nomenclature

LGMD Symptomatology

LGMD Mutations and Disease Types

Tests and Outcomes - DMD

Genes, Exons, and the Pathophysiology of DMD

The Natural History of DMD

Page 2 of 8